Rohto Pharmaceutical Co.,Ltd.
Notice Regarding the Status of Share Buyback
Total acquired shares: 595,400 ordinary shares; total acquisition amount: 1,719,225,643 yen; acquisition period: August 7, 2026 to August 31, 2026; method: market purchase (TSE).
Key Figures
- 595,400 shares: Total number of acquired shares
- 1,719,225,643 yen: Total acquisition value
- August 7, 2026–August 31, 2026: Acquisition period
AI要約
Section Heading
The notice regarding the status of share buyback clearly states the type of shares to be acquired, total number, total amount, acquisition period, and method. In this case, 595,400 ordinary shares were acquired at 1,719,225,643 yen through market purchases, with the period from August 7 to August 31, 2026. At the board meeting held on March 26, 2026, an upper limit of 1,500,000 shares and up to 30 billion yen was set; to date, the cumulative number of acquired shares remains 595,400 shares, and cumulative acquisition value remains 1,719,225,643 yen.
Section 2 Heading
This is interpreted as an effort to improve capital efficiency while avoiding detriment to shareholder value, and the possibility of additional acquisitions remains pending the remaining upper limit under the resolution. The company intends to secure liquidity and optimize internal capital through market purchases.
Rohto Pharmaceutical Co.,Ltd.
Company overview · Stock price · Financial data · All IR
